Jun 4, 2025 at 9:30 AM#16
Congrats SandraNC_45!! Keep going — you're doing incredible. 🎉
Last edited: Jun 4, 2025 at 11:30 AM
14 12NurseKim_ATL, paul_denver, TinaHashiRN and 11 others
Reply Quote Save Share Report
Jun 4, 2025 at 9:47 AM#17
tampaLisa73's experience with MASH prevalence in GLP-1 resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.
The main difference: I had more GI issues initially. But the overall trajectory has been remarkably similar. Down 41 lbs in 6 months.
One thing I would add that tampaLisa73 did not mention: insurance coverage was a major hurdle.
Last edited: Jun 4, 2025 at 10:47 AM
13 10rachel_ABQ, traveltech_sara, AttorneyGrant and 10 others
Reply Quote Save Share Report
Jun 4, 2025 at 10:04 AM#18
Bookmarked 📌 The MASH prevalence in info in this thread is essential. Coming back to this for sure.
5 0DataDave, Dr.GutHealth, amsterdam_pete and 2 others
Reply Quote Save Share Report
Jun 4, 2025 at 10:21 AM#19
Clinical perspective on MASH prevalence in GLP-1 users November:
I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.
For this specific question, I would recommend: getting comprehensive baseline labs first.
21 21Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 18 others
Reply Quote Save Share Report
Jun 4, 2025 at 10:38 AM#20
Subscribing to this thread. MASH prevalence in GLP-1 is exactly what I've been researching. 🙏
11 18LarryQC_SD, wanda_boise, NurseAsh_DET and 8 others
Reply Quote Save Share Report